The latest price target for ASP Isotopes (NASDAQ:ASPI) was reported by Canaccord Genuity on October 18, 2024. The analyst firm set a price target for $4.50 expecting ASPI to fall to within 12 months (a possible -13.29% downside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for ASP Isotopes (NASDAQ:ASPI) was provided by Canaccord Genuity, and ASP Isotopes maintained their buy rating.

There is no last upgrade for ASP Isotopes

There is no last downgrade for ASP Isotopes.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ASP Isotopes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ASP Isotopes was filed on October 18, 2024 so you should expect the next rating to be made available sometime around October 18, 2025.

While ratings are subjective and will change, the latest ASP Isotopes (ASPI) rating was a maintained with a price target of $4.50 to $4.50. The current price ASP Isotopes (ASPI) is trading at is $5.19, which is out of the analyst’s predicted range.